WOKINGHAM,
Barclays, an independent third party, will make trading decisions concerning the timing of the purchases of the Company's shares independently of the Company. Barclays will carry out the instruction through the acquisition by Barclays, as agent on behalf of the Company, of ordinary shares in the Company.
The maximum pecuniary amount allocated to this tranche of the Program is
The Company's shareholders generally authorized the Company to purchase up to a maximum of 20,398,372 of its ordinary shares at its Annual General Meeting held on
The purpose of the Program is to reduce the capital of the Company. To the extent required, the Company may in the future use the repurchased shares to satisfy share awards. Any purchases of shares by the Company in relation to this tranche of the Program will be carried out on the
About
Cautionary note regarding forward-looking statements
Certain information in this announcement is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including with relation to our share repurchase program and its purpose and timetable. Forward-looking statements cover all matters which are not historical facts and speak only as of the date on which they are made. Forward-looking statements can be identified by the use of forward-looking terminology such as 'will,' 'intend,' 'may,' or other variations or comparable terminology. Many factors could cause actual results to differ materially from those in such forward-looking statements, including, but not limited to: weakness in the economy, market trends, uncertainty and other conditions in the markets in which we operate, and other factors beyond our control, including disruption in the financial markets and any macroeconomic or other consequences of political unrest, disputes or war; failure to rapidly identify or effectively respond to direct and/or end customers' wants, expectations or trends, including costs and potential problems associated with new or upgraded information technology systems or our ability to timely deploy new omni-channel capabilities; unsuccessful execution of our operational strategies; adverse impacts caused by a public health crisis and other risks and uncertainties set forth under the heading 'Risk Factors' in our Quarterly Report on Form 10-Q filed with the
Contact:
Vice President,
Tel: +1 224 285 2410
Director, Investor Relations
Tel: +1 757 603 0111
Senior Director, Communications
Tel: +1 757 469 5813
(C) 2024 Electronic News Publishing, source